Story perspectives

2025 NFCR Summit Unites Leaders to Combat Cancer

10/7/2025

44 9

Summary

Scientists Unite Summit

The 2025 NFCR Global Summit on October 24 in Washington, D.C., unites scientists, entrepreneurs, and patient advocates.
Keynote Dr. Monica Bertagnolli will discuss funding and translational medicine, emphasizing collaboration.
Moffitt Cancer Center received $22.4 million to advance leptomeningeal disease research.
CAMFormer aims to improve early detection via non-invasive blood analysis.
Studies show inflammation and mutational burden influence colorectal cancer immunotherapy.

Summary

Oncology Innovations Surge

Immunotherapy transforms cancer treatment by using the immune system to target tumors.
GRAIL, Inc. will present Galleri data at ESMO Congress, detecting over 50 cancers.
Regulators expedited eight oncology approvals, prioritizing precision approaches over traditional methods.
Intensity Therapeutics reported a complete response in a triple-negative breast cancer patient.
GT Biopharma's GTB-3650 shows Phase 1 promise; plans to submit solid-tumor candidates.

1 of 2

Scientists Unite Summit

The 2025 NFCR Global Summit on October 24 in Washington, D.C., unites scientists, entrepreneurs, and patient advocates.
Keynote Dr. Monica Bertagnolli will discuss funding and translational medicine, emphasizing collaboration.
Moffitt Cancer Center received $22.4 million to advance leptomeningeal disease research.
CAMFormer aims to improve early detection via non-invasive blood analysis.
Studies show inflammation and mutational burden influence colorectal cancer immunotherapy.

1 / 2